Global capabilities
Delivering value beyond the test result
At Mayo Clinic Laboratories, laboratory medicine is about more than a test result — it’s about everything that contributes to providing answers for your patients. We develop individualized support solutions for each client that extend through all aspects of the relationship to ensure the delivery of answers, not just results.
Specialized testing areas include:
Global logistics and shipping
We develop unique relationships with each client to individualize logistics support, which is coordinated by a local team who ensures a seamless process before the first patient specimen is sent. Our specialists collaborate with packaging suppliers to create unique solutions that extend the stability of specimens traveling around the world.
These experts ensure specimens are handled carefully and efficiently through close connections to shipping carriers. The air carriers we work with are experienced with processing clinical specimens.
Optimized, expeditious processing
We recognize many medical conditions have a window of opportunity for the best possible outcomes. Our tests and processes are optimized to better serve patients and deliver results with outcomes in mind. We do not triage specimens across a network of labs or use a batch-testing business model. Result turnaround times are expedited by:
- Running tests continuously – your samples are processed alongside those from Mayo Clinic.
- A testing approach that incorporates comprehensive panels and algorithms when appropriate.
- Utilization of Lean and Six Sigma processes.
Reliable connectivity
We offer technology solutions to help our clients connect to us, including a secure online portal with interfacing capabilities that allows you to easily order tests and receive results. Our solutions include:
- Client-friendly test ordering through MayoLINK, which is available in eight languages.
- Expansive website with links to our open- access test catalog, which is updated daily and features comprehensive clinical information, including specimen requirements; clinical and interpretative information; performance; sample test reports; setup files; and pricing.
- 30 country-specific toll-free numbers.
News and updates
The latest
Dr. Bill Morice shares how clinical diagnostics are expanding to guide treatment and enable clinicians to target therapies more precisely.
In January, Mayo Clinic Laboratories announced a new test along with numerous reference value changes, obsolete tests, and algorithm changes.
An article authored by Jane Hermansen of Mayo Clinic Labs considers how the experiences of the pandemic will shape the lab industry in years to come.
This week’s research roundup features an expert review of the AGA clinical practice update on the management of refractory helicobacter pylori infection.
Matthew Binnicker, Ph.D., vice chair of practice for Mayo Clinic's Department of Laboratory Medicine and Pathology, joins William Morice II, M.D., Ph.D., president of Mayo Clinic Laboratories, for this week's "Answers From the Lab" leadership update. In this episode, Dr. Binnicker and Dr. Morice discuss the impact that emerging COVID-19 variants could have on virus testing, vaccine and spread.
A genetic counselor with Mayo Clinic Laboratories for the last 15 years, Cassie Runke relishes her role serving as a resource for health care providers who are looking to help their patients find answers through genetic testing.
The following list includes updates posted to mayocliniclabs.com during the month of January.
Top highlights include: understanding the effectiveness and safety of the COVID-19 vaccine, COVID-19 terminology, and a patient's experience with a new Mayo Clinic platform.
This week’s research roundup features a study on in Patients with membranous lupus nephritis, exostosin-positivity and exostosin-negativity that represent two different phenotypes.
At the beginning of the pandemic, pooled testing was seen as a way to potentially conserve valuable testing resources, but logistical hurdles and other challenges have limited its usefulness.
William Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and president of Mayo Clinic Laboratories, joins the "Answers From the Lab" podcast for his weekly leadership update. In this episode, Dr. Morice and Bobbi Pritt, M.D., discuss the new nationwide strategy that the Biden administration is rolling out to combat COVID-19.
This week’s research roundup features a study on circulating markers of NADH-reductive stress correlate with mitochondrial disease severity.
Top highlights include: maintaining your mental health during challenging times, concerns with COVID-19 variants, and unchecked COVID-19 spread leads to virus variants.